Bethesda, Maryland 20892

  • Unspecified Childhood Solid Tumor, Protocol Specific


RATIONALE: Radiation therapy may cause side effects that appear months or years after treatment has ended. A study that evaluates patients for several years after they have undergone radiation therapy may help doctors provide the best follow-up care. PURPOSE: This clinical trial is studying the late effects of radiation therapy and the natural history of disease over time in patients previously treated for cancer at the National Institutes of Health (NIH).

Study summary:

OBJECTIVES: - Continue follow-up care for long-term survivors and other patients who received radiotherapy at the National Cancer Institute's (NCI) Radiation Oncology Branch at the National Institutes of Health (NIH) in the past and for whom continued follow-up at NIH is considered beneficial to both the patient and the Radiation Oncology Branch. - Assess the natural history of the disease in these patients. - Assess late effects of treatment in these patients. OUTLINE: Patients are evaluated by Radiation Oncology Branch staff at appropriate intervals (based on good medical practices) to determine the natural history of the disease, long-term effects of previous therapies, and potential eligibility for enrollment on future protocols. Diagnostic tests, evaluations, and subsequent treatments (if needed) vary according to the individual patient's circumstances. Data is collected to assist researchers in studying long-term effects of radiotherapy and outcomes of the disease. PROJECTED ACCRUAL: A maximum of 300 patients will be accrued for this study.


DISEASE CHARACTERISTICS: - Received radiotherapy at the National Cancer Institute's (NCI) Radiation Oncology Branch at the National Institutes of Health (NIH) in the past - Not currently enrolled on an active clinical protocol at NIH - Has a primary physician to whom records and appropriate follow-up management information can be given* NOTE: *Social Services assistance will be enlisted for patients who lack health insurance. PATIENT CHARACTERISTICS: Age - Not specified Performance status - Not specified Life expectancy - Not specified Hematopoietic - Not specified Hepatic - Not specified Renal - Not specified PRIOR CONCURRENT THERAPY: Biologic therapy - Not specified Chemotherapy - Not specified Endocrine therapy - Not specified Radiotherapy - Not specified Surgery - Not specified Other - Concurrent treatment allowed as needed



Primary Contact:

Principal Investigator
Kevin Camphausen, MD
NCI - Radiation Oncology Branch; ROB

Backup Contact:


Location Contact:

Bethesda, Maryland 20892
United States

Patient Recruitment
Phone: 888-NCI-1937

Site Status: Recruiting

Data Source:

Date Processed: December 07, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.